Corradin Lab

Whitehead Institute researchers used a new approach for analyzing genetic risk data and discovered that disease-linked genes cause problems in brain cells that contribute to multiple sclerosis, which had been thought of as a solely autoimmune disease. This information could lead to the development of new therapies for multiple sclerosis, and the approach can be applied to gain insights into other diseases.

Some of the newest and brightest at Whitehead Institute discuss their current research and the future of science. Speakers include - Whitehead Institute Fellow Olivia Corradin: Uncovering New Insights into Human Disease from Genetic Risk Factors - Whitehead Institute Member Ankur Jain: Liquids, Gels, and Neurodegeneration - Whitehead Institute Fellow Kristin Knouse: Innovation in Regenerative Medicine Moderated by Nancy C. Andrews, MD, PhD, former dean of Duke University School of Medicine